Diffuse Bone Marrow Metastasis as the Initial Presentation of an Occult Breast Cancer
Open Access
- 22 July 2018
- journal article
- case report
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2018, 1-8
Abstract
Introduction. Breast cancer is one of the malignancies which tend to involve the bone marrow, but initial presentation with diffuse bone marrow metastasis from an occult breast cancer is very rare. Prognosis is generally very poor for marrow metastasis from solid tumors except that breast cancer is a treatable disease even in such a dismal condition. Case. A 64-year-old woman’s headache was found to result from diffuse adenocarcinoma metastasis in the bone marrow from an unknown primary site. Intensive immunohistochemistry study of bone marrow biopsy specimen confirmed the disease nature to be an estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer. Mammography and magnetic resonance imaging of breasts revealed a suspicious primary lesion in the right breast. Treatment with tamoxifen alone achieved a sustained response. Discussion. Mucin 1 (MUC1), also known as cancer antigen 15-3 (CA 15-3), facilitates motility and metastatic potential of breast cancer cells. Interleukin-1β (IL-1β) drives breast cancer cell growth and colonization in bone marrow adipose tissue niche. Receptor activator of nuclear factor kappa-B (RANK) and its ligand (RANKL) activate osteoclasts to make a favorable bone marrow microenvironment for tumor cells. Agents against MUC1, IL-1β, and RANKL might be of therapeutic effect for patients like ours.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow MetastasisThe Breast Journal, 2014
- MUC1 and metastatic cancerCell Adhesion & Migration, 2013
- Targeting RANKL in breast cancer: bone metastasis and beyondExpert Review of Anticancer Therapy, 2013
- Estradiol, Tamoxifen, and Flaxseed Alter IL-1β and IL-1Ra Levels in Normal Human Breast Tissue in VivoThe Journal of Clinical Endocrinology & Metabolism, 2012
- Mechanisms of Cancer Cell Metastasis to the Bone: A Multistep ProcessFuture Oncology, 2011
- Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast CancerClinical Cancer Research, 2011
- Why not treat human cancer with interleukin-1 blockade?Cancer and Metastasis Reviews, 2010
- Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samplesJournal of Cancer Research and Clinical Oncology, 2008
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004